Advertisement
A two-dose course of recombinant zoster vaccine is associated with a reduction in the incidence of herpes zoster among adults who have undergone autologous hematopoietic stem cell transplantation

Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster

0
Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT
Overall

About 12 Percent With Ankle Sprain Fill Opioid Prescriptions

0
Among opioid-naive patients, 8.4 percent of those who filled an initial opioid Rx had persistent use
Guidelines for the management and treatment of group B streptococcal disease in infants were published online July 8 in Pediatrics.

Guidance Updated for Managing Infants at Risk for Group B Strep

0
Risk assessment should consider infants born at ≥35 0/7 weeks and ≤34 6/7 weeks separately
Two new research papers

Two Algorithms Can ID Patients at Risk for HIV, PrEP Candidates

0
Algorithms use data from EHRs to identify candidates for preexposure prophylaxis
Galcanezumab can reduce the frequency of episodic cluster headache attacks

Galcanezumab Can Cut Frequency of Cluster Headache Attacks

0
Mean reduction in weekly frequency of cluster headache attacks greater with galcanezumab versus placebo
Two experimental Ebola treatments being used in the current outbreak in eastern Democratic Republic of the Congo have proved effective in laboratory tests with human cells

Lab Tests Show Experimental Ebola Treatments Effective

0
Remdesivir, ZMapp monoclonal antibodies both appear to block growth of the Ebola virus strain
For patients with atrial fibrillation

History of Liver Disease Does Not Impact Efficacy of Edoxaban

0
Patients with a-fib and history of liver disease more often had major bleeding but no increase in SSEE
Among elderly patients with prostate cancer

Androgen Deprivation Therapy May Up Risk of Alzheimer Disease

0
ADT exposure linked to subsequent Alzheimer disease diagnosis among elderly men at eight years
A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked Monday by a federal judge.

Rule Requiring Drug Prices in TV Ads Blocked by Judge

0
The rule, applying to any drug that costs more than $35 a month, was to take effect this week
Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma

Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma

0
Drug combination approved to treat patients who have failed at least five other treatments